148 related articles for article (PubMed ID: 21567493)
21. Attachment of norovirus to histo blood group antigens: a cooperative multistep process.
Mallagaray A; Lockhauserbäumer J; Hansman G; Uetrecht C; Peters T
Angew Chem Int Ed Engl; 2015 Oct; 54(41):12014-9. PubMed ID: 26329854
[TBL] [Abstract][Full Text] [Related]
22. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
Maurer T
Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
[TBL] [Abstract][Full Text] [Related]
23. Fucose-Functionalized Precision Glycomacromolecules Targeting Human Norovirus Capsid Protein.
Bücher KS; Yan H; Creutznacher R; Ruoff K; Mallagaray A; Grafmüller A; Dirks JS; Kilic T; Weickert S; Rubailo A; Drescher M; Schmidt S; Hansman G; Peters T; Uetrecht C; Hartmann L
Biomacromolecules; 2018 Sep; 19(9):3714-3724. PubMed ID: 30071731
[TBL] [Abstract][Full Text] [Related]
24. Potent human immunodeficiency virus type 1 protease inhibitors that utilize noncoded D-amino acids as P2/P3 ligands.
Jungheim LN; Shepherd TA; Baxter AJ; Burgess J; Hatch SD; Lubbehusen P; Wiskerchen M; Muesing MA
J Med Chem; 1996 Jan; 39(1):96-108. PubMed ID: 8568831
[TBL] [Abstract][Full Text] [Related]
25. (E)-2-styrylchromones as potential anti-norovirus agents.
Rocha-Pereira J; Cunha R; Pinto DC; Silva AM; Nascimento MS
Bioorg Med Chem; 2010 Jun; 18(12):4195-201. PubMed ID: 20554208
[TBL] [Abstract][Full Text] [Related]
26. Exploring the active site of human factor Xa protein by NMR screening of small molecule probes.
Fielding L; Fletcher D; Rutherford S; Kaur J; Mestres J
Org Biomol Chem; 2003 Dec; 1(23):4235-41. PubMed ID: 14685325
[TBL] [Abstract][Full Text] [Related]
27. Trapping norovirus by glycosylated hydrogels: a potential oral antiviral drug.
Zhang Y; Yao Q; Xia C; Jiang X; Wang PG
ChemMedChem; 2006 Dec; 1(12):1361-6. PubMed ID: 17042040
[No Abstract] [Full Text] [Related]
28. Structural Basis for Norovirus Inhibition by Human Milk Oligosaccharides.
Weichert S; Koromyslova A; Singh BK; Hansman S; Jennewein S; Schroten H; Hansman GS
J Virol; 2016 May; 90(9):4843-4848. PubMed ID: 26889023
[TBL] [Abstract][Full Text] [Related]
29. Discovery and Synthesis of Heterocyclic Carboxamide Derivatives as Potent Anti-norovirus Agents.
Ohba M; Oka T; Ando T; Arahata S; Ikegaya A; Takagi H; Ogo N; Owada K; Kawamori F; Wang Q; Saif LJ; Asai A
Chem Pharm Bull (Tokyo); 2016; 64(5):465-75. PubMed ID: 27150478
[TBL] [Abstract][Full Text] [Related]
30. Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle.
Tan M; Jiang X
Trends Microbiol; 2005 Jun; 13(6):285-93. PubMed ID: 15936661
[TBL] [Abstract][Full Text] [Related]
31. Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design.
Rhodes DI; Peat TS; Vandegraaff N; Jeevarajah D; Le G; Jones ED; Smith JA; Coates JA; Winfield LJ; Thienthong N; Newman J; Lucent D; Ryan JH; Savage GP; Francis CL; Deadman JJ
Antivir Chem Chemother; 2011 Mar; 21(4):155-68. PubMed ID: 21602613
[TBL] [Abstract][Full Text] [Related]
32. Association of histo-blood group antigens and susceptibility to norovirus infections.
Rockx BH; Vennema H; Hoebe CJ; Duizer E; Koopmans MP
J Infect Dis; 2005 Mar; 191(5):749-54. PubMed ID: 15688291
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and evaluation of monovalent ligands for the asialoglycoprotein receptor (ASGP-R).
Stokmaier D; Khorev O; Cutting B; Born R; Ricklin D; Ernst TO; Böni F; Schwingruber K; Gentner M; Wittwer M; Spreafico M; Vedani A; Rabbani S; Schwardt O; Ernst B
Bioorg Med Chem; 2009 Oct; 17(20):7254-64. PubMed ID: 19762243
[TBL] [Abstract][Full Text] [Related]
34. Norovirus Binding to Ligands Beyond Histo-Blood Group Antigens.
Almand EA; Moore MD; Jaykus LA
Front Microbiol; 2017; 8():2549. PubMed ID: 29312233
[TBL] [Abstract][Full Text] [Related]
35. Complete relaxation and conformational exchange matrix (CORCEMA) analysis of intermolecular saturation transfer effects in reversibly forming ligand-receptor complexes.
Jayalakshmi V; Krishna NR
J Magn Reson; 2002 Mar; 155(1):106-18. PubMed ID: 11945039
[TBL] [Abstract][Full Text] [Related]
36. Identification of MMP-12 inhibitors by using biosensor-based screening of a fragment library.
Nordström H; Gossas T; Hämäläinen M; Källblad P; Nyström S; Wallberg H; Danielson UH
J Med Chem; 2008 Jun; 51(12):3449-59. PubMed ID: 18494455
[TBL] [Abstract][Full Text] [Related]
37. Porcine gastric mucin binds to recombinant norovirus particles and competitively inhibits their binding to histo-blood group antigens and Caco-2 cells.
Tian P; Brandl M; Mandrell R
Lett Appl Microbiol; 2005; 41(4):315-20. PubMed ID: 16162137
[TBL] [Abstract][Full Text] [Related]
38. An in silico virtual screening study for the design of norovirus inhibitors: fragment-based molecular docking and binding free energy calculations.
Lundborg M; Ali E; Widmalm G
Carbohydr Res; 2013 Aug; 378():133-8. PubMed ID: 23582100
[TBL] [Abstract][Full Text] [Related]
39. A solution NMR study of the interactions of oligomannosides and the anti-HIV-1 2G12 antibody reveals distinct binding modes for branched ligands.
Enríquez-Navas PM; Marradi M; Padro D; Angulo J; Penadés S
Chemistry; 2011 Feb; 17(5):1547-60. PubMed ID: 21268157
[TBL] [Abstract][Full Text] [Related]
40. Ligand-receptor binding affinities from saturation transfer difference (STD) NMR spectroscopy: the binding isotherm of STD initial growth rates.
Angulo J; Enríquez-Navas PM; Nieto PM
Chemistry; 2010 Jul; 16(26):7803-12. PubMed ID: 20496354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
